---
schema_version: "secwatch.filing_event.v1"
accession: "0001171843-26-002096"
form_type: "8-K"
ticker: "AGPU"
cik: "0001446159"
company_name: "Axe Compute Inc."
filed_at: "2026-03-31T23:59:59+00:00"
generated_at: "2026-05-15T08:08:31.999502+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Axe Compute reports FY2025 net loss of $232.9M; no compute revenue; holds $40M in ATH tokens

## Summary
- Total revenue $125,284, entirely from legacy Drug Discovery; no compute revenue in 2025.
- Net loss from continuing ops $232.9M, including $152.5M unrealized loss on digital assets (ATH) and $52.7M derivative loss.
- Cash and equivalents $10.8M vs $0.6M; stockholders' equity improved to $47.7M from deficit of $0.2M.
- Held 6.348B ATH tokens aggregate ($40M FMV after discount); $343.5M raised via PIPE in Oct 2025.
- CEO Christopher Miglino appointed Feb 2026; board reconstituted; GPU network access over 435,000 GPUs established.

## SEC filing metadata
- accession: 0001171843-26-002096
- form_type: 8-K
- ticker: AGPU
- cik: 0001446159
- company_name: Axe Compute Inc.
- filed_at: 2026-03-31T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1446159/000117184326002096/0001171843-26-002096-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1446159/000117184326002096/f8k_033126.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001171843-26-002096
- JSON: https://secwatch.observer/filing/0001171843-26-002096.json
- Plain text: https://secwatch.observer/filing/0001171843-26-002096.txt

## Key facts
- Earnings Releases
  Axe Compute Inc. reported the fiscal year ended December 31, 2025 results: revenue $125,284, net income $232.9 million.
  - Period: the fiscal year ended December 31, 2025
  - Revenue: $125,284
  - Net income: $232.9 million
  - Result: reported results
  source text: center facilities or GPU hardware; the Company’s platform provides marketplace access to this network on an asset-light model. FULL YEAR 2025 FINANCIAL HIGHLIGHTS Total Revenue: $125,284, derived entirely from the Company’s Drug Discovery Services legacy segment. No compute revenue was recognized in fiscal 2025, as the Axe Compute segment launched in September 2025
  evidence_url: https://www.sec.gov/Archives/edgar/data/1446159/000117184326002096/0001171843-26-002096-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.